Alliance Pharma a 'buy' after trading statement, says Numis - Proactive Investors UK
Wed, 06 Jul 2011 13:42Alliance paid £2.6 million cash to acquire the two brands. Numis, Alliance's house broker, said that it would maintain its 37 pence per share price target, “assuming the company can achieve 2011 and 2012 EBITDA and earnings multiples in line with its ...
Broker Roundup: Lloyds Bank, Rio Tinto, Aquarius Platinum, Lonmin, Ferrexpo ... - Proactive Investors UK
Wed, 06 Jul 2011 15:23Numis Securities has upgraded Alliance Pharma (LON:APH) from 'hold' to 'buy' after the speciality pharmaceuticals company said that recent trading had been in line with management expectations. Fellow broker FinnCap also commented, saying that the ...
Mid and small cap news: Bovis Homes, Moneysupermarket.com, Smiths News, Flybe ... - Proactive Investors UK
Sat, 09 Jul 2011 11:20In a note to investors, the research house said that the stock is attractively priced at current levels, and the group's current guidance appears conservative. Speciality pharmaceuticals firm Alliance Pharma (LON:APH) said this week that recent trading ...
Markets: Portugal rating cut hits FTSE 100 - Interactive Investor
Wed, 06 Jul 2011 11:0116:05 - Alliance Pharma (APH) said today that trading in the first half of the year had been in line with management expectations, with sales marginally ahead of the same period the year before. AIM-listed Alliance said sales for the six months to ...
Seth Klarman's Top 10 Long Ideas - Seeking Alpha
Fri, 08 Jul 2011 12:18The Street expects Alliance One to earn $0.25 per share in FY12 (13x P/E). The company trades at 1.1x tangible book value of $272 million. Allied Nevada Gold (ANV) ($35 per share; MV $3.1 billion; EV $2.8 billion), based in Reno, NV, owns the Hycroft ...
Sector:
